习惯性流产国际专利保胎技术International patent fetal protection technology for habitual abortion
After decades of research and clinical practice, Chen fenglin has successfully developed a new immunotherapy method for habitual abortion. The cure rate is more than 95%, and this achievement won the second prize of Beijing science and technology progress in 1997. On May 24, 2004, Chen fenglin, dean of the road to health system elaborated on the diagnosis and treatment of habitual abortion. Immunotherapy for habitual abortion has been patented in 29 countries at home and abroad, which marks that China's infertility treatment institutions are in line with the international standard and have reached and surpassed the world's advanced level.